Why you should select your drug formulation before starting clinical studies
創薬企業はしばしば、ヒトでの試験を急ぐあまり、創薬プロセスを駆け足で進めてしまうことがあります。Most are…
Certara2022年10月28日
3 Takeaways from the FDA Oligo Guidance You Need to Know
In June 2022, the FDA published their first oligonucleotide clinical pharmacology specific guidance . This…
Certara2022年9月23日
Predicting and Taming Immunogenicity: Strategies for your Biologic Drug
Immunogenicity is the ability of a foreign substance, such as a drug or vaccine, to…
Certara2021年11月19日
Dose Optimization Using Population PK for an Orphan Drug
RAPALIMUS® Tablets (sirolimus) is Nobelpharma’s orphan drug developed from an oral medication that is sold…
Certara2021年11月17日
A Day in the Life of a Clinical Pharmacology Consultant
Strategic consulting within drug discovery and development is an exciting career choice for many. Unlike…
Certara2021年10月8日
Building a Robust Clinical Pharmacology & Model-Informed Drug Development Strategy for New Alzheimer’s Disease Drugs
Alzheimer's disease (AD) is one of the most common forms of neurodegenerative dementia in the…
Certara2021年9月20日
バイオ医薬品における臨床薬理計画の全体像とは？
Monoclonal antibodies are now widely used in the treatment of several diseases, providing effective and…
Certara2021年8月6日
Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success
Antibody drug conjugates (ADC) are a unique way to obliterate tumor cells and represent an…
Certara2021年7月8日
8 Tips for Successfully Developing Oligonucleotide Therapies
By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…
Certara2021年2月1日
